Maternal folic acid supplementation and the risk of ankyloglossia (tongue-tie) in infants; a systematic review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 07 08 2023
accepted: 25 10 2023
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: epublish

Résumé

Maternal folic acid supplementation is protective against the development of neural tube defects (NTDs) in babies. However, recent public-facing communications have raised concerns about a causal relationship between folic acid supplementation, particularly after the first trimester, and ankyloglossia (tongue-tie) in infants. Non-evidence-based communications are potentially harmful because they could adversely affect adherence to folic acid supplementation, increasing NTD occurrence. This study aimed to review evidence on the relationships between maternal folic acid supplementation during preconception and/or pregnancy and the risk of ankyloglossia in infants. We searched the databases MEDLINE, EMBASE, Cochrane CENTRAL, and Scopus. We searched for observational, and interventional studies, and systematic reviews investigating the effect of maternal folic acid supplementation during preconception or pregnancy on the occurrence of ankyloglossia in offspring. The search was registered on PROSPERO on 01/12/2022, ID: CRD42022375862. The database searches yielded 93 articles. After removing duplicates and screening titles and abstracts, 26 remained. One article was judged relevant for inclusion in analyses; a case-control study that directly mentions the relationship between folic acid supplementation and ankyloglossia. This study reported that regular intake of folic acid supplements was higher in women with infants with ankyloglossia. However, this study has limitations regarding design, selection bias, and confounding, calling the findings into question. Insufficient evidence exists for a relationship between folic acid supplementation and ankyloglossia. Currently, the benefits of folic acid supplementation far outweigh the risks. This must be clearly communicated to patients by their clinicians during preconception and antenatal care.

Sections du résumé

BACKGROUND
Maternal folic acid supplementation is protective against the development of neural tube defects (NTDs) in babies. However, recent public-facing communications have raised concerns about a causal relationship between folic acid supplementation, particularly after the first trimester, and ankyloglossia (tongue-tie) in infants. Non-evidence-based communications are potentially harmful because they could adversely affect adherence to folic acid supplementation, increasing NTD occurrence. This study aimed to review evidence on the relationships between maternal folic acid supplementation during preconception and/or pregnancy and the risk of ankyloglossia in infants.
METHODS
We searched the databases MEDLINE, EMBASE, Cochrane CENTRAL, and Scopus. We searched for observational, and interventional studies, and systematic reviews investigating the effect of maternal folic acid supplementation during preconception or pregnancy on the occurrence of ankyloglossia in offspring. The search was registered on PROSPERO on 01/12/2022, ID: CRD42022375862.
RESULTS
The database searches yielded 93 articles. After removing duplicates and screening titles and abstracts, 26 remained. One article was judged relevant for inclusion in analyses; a case-control study that directly mentions the relationship between folic acid supplementation and ankyloglossia. This study reported that regular intake of folic acid supplements was higher in women with infants with ankyloglossia. However, this study has limitations regarding design, selection bias, and confounding, calling the findings into question.
CONCLUSIONS
Insufficient evidence exists for a relationship between folic acid supplementation and ankyloglossia. Currently, the benefits of folic acid supplementation far outweigh the risks. This must be clearly communicated to patients by their clinicians during preconception and antenatal care.

Identifiants

pubmed: 37922258
doi: 10.1371/journal.pone.0294042
pii: PONE-D-23-25110
pmc: PMC10624271
doi:

Substances chimiques

Folic Acid 935E97BOY8

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0294042

Informations de copyright

Copyright: © 2023 Rubin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nutrients. 2015 Apr 10;7(4):2663-86
pubmed: 25867949
Lancet. 2021 Oct 2;398(10307):1199-1201
pubmed: 34562392
J Nutr. 2010 May;140(5):1014-22
pubmed: 20335637
Med Hypotheses. 2020 Jan;134:109508
pubmed: 31835174
Am J Clin Nutr. 2013 Jul;98(1):92-8
pubmed: 23719554
PLoS One. 2021 Oct 21;16(10):e0258488
pubmed: 34673787
Nutrients. 2020 Jan 18;12(1):
pubmed: 31963665
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):1-5
pubmed: 25590678
Birth Defects Res A Clin Mol Teratol. 2005 Oct;73(10):679-89
pubmed: 16240378
BMC Med. 2019 Oct 31;17(1):196
pubmed: 31672132
J Prenat Med. 2008 Oct;2(4):40-1
pubmed: 22439027
BMJ. 2005 Mar 12;330(7491):571
pubmed: 15722368
Ann N Y Acad Sci. 2018 Nov;1431(1):35-57
pubmed: 30239016
Can Fam Physician. 2007 Jun;53(6):1027-33
pubmed: 17872781
JAMA. 2017 Jan 10;317(2):183-189
pubmed: 28097362
Otolaryngol Head Neck Surg. 2020 May;162(5):597-611
pubmed: 32283998
BJOG. 2015 Mar;122(4):478-90
pubmed: 25424556
Clin Pediatr (Phila). 2020 Sep;59(9-10):885-892
pubmed: 32462918
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
CMAJ Open. 2016 Jan 26;4(1):E33-40
pubmed: 27280112
Obstet Gynecol Int. 2012;2012:485179
pubmed: 22529856
Otolaryngol Clin North Am. 2019 Oct;52(5):795-811
pubmed: 31353141
Arch Dis Child Fetal Neonatal Ed. 2014 May;99(3):F189-95
pubmed: 24249695
An Pediatr (Barc). 2014 Aug;81(2):115-9
pubmed: 24286885
Epigenet Insights. 2020 Dec 18;13:2516865720981924
pubmed: 33415317
Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110212
pubmed: 32738672

Auteurs

Gal Rubin (G)

UCL EGA Institute for Women's Health, Reproductive Health Research Dept, UCL, London, United Kingdom.
Minerva University: College of Natural Sciences, San Francisco, CA, United States America.

Catherine Stewart (C)

UCL EGA Institute for Women's Health, Reproductive Health Research Dept, UCL, London, United Kingdom.

Laura McGowan (L)

Centre for Public Health, Institute for Global Food Security, Queen's University Belfast, Belfast, Ireland.

Jayne V Woodside (JV)

Centre for Public Health, Institute for Global Food Security, Queen's University Belfast, Belfast, Ireland.

Geraldine Barrett (G)

UCL EGA Institute for Women's Health, Reproductive Health Research Dept, UCL, London, United Kingdom.

Keith M Godfrey (KM)

MRC Lifecourse Epidemiology Centre and NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Jennifer Hall (J)

UCL EGA Institute for Women's Health, Reproductive Health Research Dept, UCL, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH